Chemotherapy Research and Practice
Volume 2012 (2012), Article ID 549170, 5 pages
Clinical Study

Induction Chemotherapy in Locally Advanced Pharyngolaryngeal Cancers with Stridor: Is It Feasible and Safe?

1Department of Medical Oncology, Tata Memorial Hospital, Mumbai 400012, India
2Department of Surgical Oncology, Tata Memorial Hospital, Mumbai 400012, India
3Department of Radio-Diagnosis, Tata Memorial Hospital, Mumbai 400012, India

Received 1 May 2012; Revised 5 July 2012; Accepted 6 July 2012

Academic Editor: Vassilios A. Georgoulias

Copyright © 2012 Vijay Maruti Patil et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [2 citations]

The following is the list of published articles that have cited the current article.

  • V. Patil, V. Noronha, A. Joshi, Vamshi Muddu Krishna, S. Juvekar, Gauri Pantvaidya, Pankaj Chaturvedi, D. Chaukar, Supreeta Arya, Aswari Patil, B. Bhosale, A. Dongre, A. K. Dcruz, and K. Prabhash, “Is There a Limitation of RECIST Criteria in Prediction of Pathological Response, in Head and Neck Cancers, to Postinduction Chemotherapy?,” ISRN Oncology, vol. 2013, pp. 1–6, 2013. View at Publisher · View at Google Scholar
  • V. M. Patil, S. Chakraborty, P. K. Shenoy, A. Manuprasad, Sajith T. P. Babu, T. Shivkumar, S. Babu, A. Bhatterjee, and S. Balasubramanian, “Tolerance and toxicity of neoadjuvant docetaxel, cisplatin and 5 fluorouracil regimen in technically unresectable oral cancer in resource limited rural based tertiary cancer center,” Indian Journal of Cancer, vol. 51, no. 1, pp. 69–72, 2014. View at Publisher · View at Google Scholar